Lidocaine Hydrochloride, Usp And D-glucose Monohydrate Structural Formula Images (Image 01)
Lidocaine Hydrochloride And Dextrose Injection, Solution
Product Images NDC 0338-0409
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride And Dextrose (NDC 0338-0409). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Lidocaine Hydrochloride Representative Container Label Ndc 0338-0411-02 (Image 02)
LOT EXP NDC 0338-0411-02 is a Lidocaine Hydrochloride and 5% Dextrose Injection USP containing 2 g per 250 mL (8 mg/mL). Each 100 mL of the sterile single dose container contains 800 mg Lidocaine HCI USP and 5 g Dextrose Hyprous USP with a pH of 4.0 (3.0 707.0) OsMOLARITY of 311 mOsmol/L (cac). The usual dosage is specified in the STK insert and it should not be used with supplementary medication other than a calibrated infusion device. The product can be stored in moisture barrier overwrap at room temperature (77°F or 25°C) until ready to use. The manufacturer is Baxter and it is meant for Rx only.*
Lidocaine Hydrochloride 0338-0411-02 Representative Carton Label (Image 03)
The text describes a lot number (T123456) and an expiration date (JAN 2020) for a medical product. The product is probably Lidocaine hydrochloride, with a concentration of 2g per 250mL, mixed with 5% dextrose in injection form. The code 280962 could refer to the product code.*
Lidocaine Hydrochloride Representative Container Label Ndc0338-0409-03 (Image 04)
This is a description of a drug called "Lidocaine Hydrochloride and 5% Dextrose Injection USP". It is available in a sterile single dose container with a volume of 500 mL. Each 100 mL of the injection contains 400 mg of Lidocaine HCI and 5 g of Dextrose Hyprous USP. The usual dosage information is available in the insert, and no supplementary medication should be added. It can only be used with a calibrated infusion device and should be stored at room temperature until ready to use. It is a prescription drug manufactured by Baxter.*
Lidocaine Hydrochloride Representative Carton Label 0338-0409-03 (Image 05)
This text appears to be a label of a medication called "5% Dextrose Injection, USP" with lot number T123456 and expiry date of January 2020. The label also shows the quantity per container (500mL) and a product code (280973). Not enough information is provided to determine the intended use or specific ingredients of this medication.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
